Occurrence and number of immune-related adverse events are independently associated with survival in advanced non-small-cell lung cancer treated by nivolumab
Titel:
Occurrence and number of immune-related adverse events are independently associated with survival in advanced non-small-cell lung cancer treated by nivolumab
Auteur:
Bouhlel, Linda Doyen, Jérôme Chamorey, Emmanuel Poudenx, Michel Ilie, Marius Gal, Jocelyn Guigay, Joël Benzaquen, Jonathan Marquette, Charles-Hugo Berthet, Jean-Philippe Mouroux, Jérôme Schiappa, Renaud Padovani, Bernard Hofman, Paul Otto, Josiane